Ectonucleoside Triphosphate Diphosphohydrolase-1/CD39 Affects the Response to ADP of Female Rat Platelets.

CD39 adenosine diphosphate aggregation inflammation platelet rat sex thrombosis

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2019
Historique:
received: 20 09 2019
accepted: 24 12 2019
entrez: 22 2 2020
pubmed: 23 2 2020
medline: 23 2 2020
Statut: epublish

Résumé

There is evidence that an imbalance of extracellular purine levels may be associated with increased cardiovascular risk. Platelets play a pivotal role in vascular homeostasis and thrombosis and are important source of purine nucleotides and nucleosides. Hydrolysis of nucleotides ATP and ADP is regulated by two ectonucleotidases, triphosphate diphosphohydrolase-1 (NTPDase-1/CD39) and ecto-5'-nucleotidase (ecto-5'-NT/CD73). CD39 enzyme is expressed on the endothelium, circulating blood cells, and smooth muscle cells; there is evidence that changes in CD39 expression and activity affects the potential thrombogenic of a tissue. Gender difference in the cardiovascular risk has been extensively observed; however, while the age-dependent difference in the prevalence of cardiovascular events between men and women has been attributed to the loss of the protective effect of estrogens in the postmenopausal period, the physiological mechanism behind gender disparity is still unclear. Here, we evaluated comparatively male and female rat platelet reactivity and considered the possible role of CD39 at the basis of difference observed. We found a reduced

Identifiants

pubmed: 32082171
doi: 10.3389/fphar.2019.01689
pmc: PMC7005199
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1689

Informations de copyright

Copyright © 2020 Caiazzo, Bilancia, Rossi, Ialenti and Cicala.

Références

J Am Coll Cardiol. 2009 Nov 17;54(21):1935-45
pubmed: 19909874
Eur J Pharmacol. 2007 Dec 22;577(1-3):156-61
pubmed: 17850787
Purinergic Signal. 2009 Sep;5(3):335-42
pubmed: 19308674
Thromb Res. 1999 May 1;94(3):187-97
pubmed: 10326765
Interv Cardiol Clin. 2012 Apr;1(2):223-230
pubmed: 28582096
Blood. 2002 Apr 15;99(8):2801-9
pubmed: 11929769
Sci Adv. 2019 Aug 21;5(8):eaax1387
pubmed: 31457100
Endocr J. 2001 Feb;48(1):33-41
pubmed: 11403101
J Pharmacol Exp Ther. 2000 Dec;295(3):862-9
pubmed: 11082418
Trends Mol Med. 2013 Jun;19(6):355-67
pubmed: 23601906
J Thromb Haemost. 2008 Jul;6(7):1191-7
pubmed: 18485080
Platelets. 2005 Sep;16(6):334-9
pubmed: 16194863
Biol Sex Differ. 2017 Oct 24;8(1):33
pubmed: 29065927
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1809-20
pubmed: 27417582
Cardiovasc Drugs Ther. 2015 Aug;29(4):403-10
pubmed: 26227895
Life Sci. 1998;62(20):1817-24
pubmed: 9600323
Nat Prod Commun. 2016 Jun;11(6):771-4
pubmed: 27534113
Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):279-83
pubmed: 19221204
Circ Res. 2017 Jan 6;120(1):207-228
pubmed: 28057794
Annu Rev Physiol. 2011;73:503-14
pubmed: 20887194
Neurol Neurochir Pol. 2019;53(4):258-264
pubmed: 31343071
Adv Pharmacol. 2011;61:301-32
pubmed: 21586363
Purinergic Signal. 2006 Jun;2(2):409-30
pubmed: 18404480
Int J Inflam. 2014;2014:247503
pubmed: 24940514
Future Cardiol. 2011 May;7(3):403-13
pubmed: 21627479
Purinergic Signal. 2017 Jun;13(2):259-265
pubmed: 28343356
Hematol Oncol Clin North Am. 2013 Jun;27(3):411-41
pubmed: 23714306
Eur Heart J. 2014 Sep 1;35(33):2213-23b
pubmed: 25024407
Crit Care Med. 2019 May;47(5):e420-e427
pubmed: 30730441
J Am Coll Cardiol. 2017 Oct 3;70(14):1760-1776
pubmed: 28958334
Circ Res. 2015 Mar 27;116(7):1206-15
pubmed: 25645301
Atherosclerosis. 2006 Jun;186(2):240-59
pubmed: 16343508
Pharmacol Res. 2017 May;119:36-47
pubmed: 28131875
J Clin Invest. 2019 Apr 16;129(7):2872-2877
pubmed: 30990798
Blood Cells Mol Dis. 2006 Mar-Apr;36(2):217-22
pubmed: 16476557
Eur J Pharmacol. 2009 Jun 10;612(1-3):29-34
pubmed: 19356727
Am J Pathol. 2012 Jul;181(1):322-33
pubmed: 22613024
Lancet. 2014 Mar 15;383(9921):999-1008
pubmed: 24084292
J Autoimmun. 2018 Mar;88:131-138
pubmed: 29103803
Thromb Res. 2007;121(3):309-17
pubmed: 17555802
Purinergic Signal. 2011 Sep;7(3):293-303
pubmed: 21792575
Neth Heart J. 2011 Nov;19(11):451-7
pubmed: 21901505
J Am Heart Assoc. 2017 Jul 27;6(8):
pubmed: 28751543
Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):e118-e129
pubmed: 30816804
Pharmacol Res. 2019 Jan;139:182-190
pubmed: 30468889
J Physiol. 1963 Aug;168:178-95
pubmed: 14056485
Blood. 2004 Sep 15;104(6):1745-52
pubmed: 15187029
J Mol Neurosci. 2017 Mar;61(3):412-422
pubmed: 27981418
Cell Biochem Biophys. 2013 Mar;65(2):129-43
pubmed: 22956389
Mol Neurobiol. 2019 Mar;56(3):1933-1945
pubmed: 29978426
Nature. 2010 Jun 10;465(7299):688-9
pubmed: 20535184
Nat Rev Drug Discov. 2006 May;5(5):425-38
pubmed: 16672926
Nature. 1975 Jan 31;253(5490):355-7
pubmed: 1110780
Int J Lab Hematol. 2013 Jun;35(3):254-61
pubmed: 23590652
Thromb Res. 2018 Oct;170:192-199
pubmed: 30199785
J Cell Physiol. 2011 Jan;226(1):46-51
pubmed: 20717958

Auteurs

Elisabetta Caiazzo (E)

Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Rossella Bilancia (R)

Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Antonietta Rossi (A)

Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Armando Ialenti (A)

Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Carla Cicala (C)

Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Classifications MeSH